SCHEMBL786831

SCHEMBL786831

[NH]Cc1cc([N+](=O)[O-])ccc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
TSHR P16473 3/20 0.56
GPR35 Q9HC97 2/20 0.56
TP53 P04637 1/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GAA P10253 1/20 0.55
THRB P10828 1/20 0.55
CTSB P07858 1/20 0.54
ERN1 O75460 1/20 0.51
NOX4 Q9NPH5 1/20 0.49
APP P05067 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
HSP90AA1 P07900 1/20 0.45
MEN1 O00255 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22773531 0.85 GPR35 (0.56) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL51277 0.85 GPR35 (0.60) ALDH1A1TSHRGPR35TP53HPGD
Hydrochloric Acid SCHEMBL30105737 0.84 TSHR (0.55) ALDH1A1TSHRGPR35TP53HPGD
Hydrochloric Acid SCHEMBL9501431 0.84 GAA (0.58) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL216753 0.83 GPR35 (0.58) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL4231830 0.83 ALDH1A1 (0.58) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL4006539 0.82 ERN1 (0.57) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL360284 0.81 TSHR (0.56) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL786832 0.81 GAA (0.59) ALDH1A1TSHRGPR35TP53HPGD
SCHEMBL131912 0.81 GPR35 (0.56) ALDH1A1TSHRGPR35TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438068-B1 SUBSTITUTED 6-(2-HYDROXYBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2017-03-01 EP disclosed
US-8492391-B2 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2013-07-23 US disclosed
US-20120070512-A1 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives BIOPATTERNS, S.R.O (CZ) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070512-A1 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives CDK6, CCNI, CDK2 ALDH1A1 1242/4885TSHR 4684/4885GPR35 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.